Levofloxacin to prevent first infection in childhood ALL
Treatments studied
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial tests whether taking the antibiotic levofloxacin can prevent a first serious infection (febrile neutropenia) in children with ALL during the first weeks of chemotherapy. It aims to keep kids safer during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 1 and 18 years old.
- You have been diagnosed with acute lymphoblastic leukemia (ALL).
- You are about to start the first phase of chemotherapy (induction) for your ALL.
- You are not allergic to levofloxacin (a type of antibiotic).
- You do not have an active infection that needs more than 5 days of antibiotics right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two antibiotics, ciprofloxacin and ceftazidime, to see which works better for treating fever in children with blood cancer who have a high risk of infection due to low white blood cells. The goal is to find the best treatment to help your child recover faster.
This trial tests a treatment plan for adults aged 18 to 65 who have just been diagnosed with a type of acute lymphoblastic leukemia (ALL) that does not have the Philadelphia chromosome (Ph-negative). The goal is to see how well this therapy works and how safe it is.
This trial tests a standard chemotherapy regimen for people aged 18 to 50 with a type of leukemia called Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL). It aims to see how well the treatment works for this age group.
This early-phase study tests whether levocarnitine can reduce liver injury from a chemotherapy medicine called asparaginase in people with high-risk acute lymphoblastic leukemia (ALL). If you’re eligible, you would take levocarnitine by mouth alongside your planned standard cancer treatment to see if the liver stays healthier.
This trial tests if an antibiotic called dalbavancin can help prevent serious bacterial infections in children and young adults with high-risk leukemia whose immune systems are weakened by treatment.
This trial tests whether giving antibiotics to prevent infections helps patients with myelodysplastic syndromes or acute myeloid leukemia who are starting a specific type of chemotherapy called hypomethylating agents. Preventing infections could help patients stay healthier during treatment.
Hear when a new Neutropenic Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.